Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - Chronic Obstructive Pulmonary Disease
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

clinical topic updates

Optimal Use of Imaging in Rheumatoid Arthritis

Optimal Use of Imaging in Rheumatoid Arthritis

clinical topic updates
By Eric M. Ruderman, MD

Radiographic Progression From Factors Other Than High Disease Activity in the Current Treat-to-Target Paradigm

Radiographic Progression From Factors Other Than High Disease Activity in the Current Treat-to-Target Paradigm

clinical topic updates
By Eric M. Ruderman, MD

Potential Use of Bispecific Antibodies Designed to Target CD20 on B Cells and CD3 on T Cells

Potential Use of Bispecific Antibodies Designed to Target CD20 on B Cells and CD3 on T Cells

clinical topic updates
By Julie M. Vose, MD, MBA, FASCO

Potential Role of BCL-2 Inhibition in the Treatment of Mantle Cell Lymphoma

Potential Role of BCL-2 Inhibition in the Treatment of Mantle Cell Lymphoma

clinical topic updates
By Brad Kahl, MD

$Immunomodulator-Based Triplet Therapy in Patients With Relapsed/Refractory Multiple Myeloma$

Immunomodulator-Based Triplet Therapy in Patients With Relapsed/Refractory Multiple Myeloma

clinical topic updates
By Carol Ann Huff, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?